Trial Profile
Effect of fingolimod in comorbid migraine in patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Migraine; Multiple sclerosis
- Focus Therapeutic Use
- 05 Dec 2015 New trial record